Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-27

Clinical Trial Update: Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the efficacy and safety of dexamethasone to prevent ovarian hyperstimulation syndrome in patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Ovarian Hyperstimulation Syndrome | Phase 2 | Status: UNKNOWN